Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...